Literature DB >> 3553494

Initial therapy in hypertension: quality-of-life considerations.

N K Hollenberg.   

Abstract

Treatment has one of two fundamental goals, relief of symptoms or a change in natural history. In general, a treatment goal of symptom relief is easier to achieve. One treats each day for symptoms that day, and a patient's compliance is maintained when symptoms are relieved. Treatment that has as its goal a change in natural history, without providing symptom relief, is fundamentally more difficult: one treats today for events that might occur tomorrow--or months or years later. The revolution in what we have available for treatment has been accompanied by an evolution in expectations. In the area of hypertension the expectations are stringent. The physician cannot provide the patient with symptom relief, because there are no symptoms directly attributable to the hypertension--although few individuals are free of symptoms. The short-term goal is to control the high blood pressure at a minimal cost in adverse reactions; the long-term goal is to change natural history. Two decades ago antihypertensive therapy was restricted to very severe hypertension. The available agents were difficult to use, and they produced substantial side effects. Over the past several decades each wave of new agents has provided some improvement in efficacy, but primarily a reduction in the frequency and severity of adverse reactions. Today, at a time when we often wish to treat mild hypertension, the goal is to have patients feel as well on treatment as they do off it. A progressive reduction in the frequency and severity of central nervous system side effects is one of the major features of the evolution of therapy.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3553494

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  3 in total

1.  Correlation of quality of life with clinical symptoms and signs at the time of glaucoma diagnosis.

Authors:  R P Mills
Journal:  Trans Am Ophthalmol Soc       Date:  1998

2.  Effects of diltiazem and metoprolol on blood pressure, adverse symptoms and general well-being. The Swedish Diltiazem-Metoprolol Multi-Centre Study Group.

Authors:  C Dahlöf; T Hedner; T Thulin; S Gustafsson; S O Olsson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 3.  The effect of antihypertensive treatment on the quality of later years.

Authors:  M A James; J F Potter
Journal:  Drugs Aging       Date:  1993 Jan-Feb       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.